| 101 |
19701552 | [Economic impact of Losartan use in type 2 diabetic patients with nephropathy]. | 2009 May |
2 |
| 102 |
19781192 | [NADPH oxidase-derived reactive oxygen species involved in angiotensin II-induced monocyte chemoattractant protein-1 expression in mesangial cells]. | 2009 Jul |
1 |
| 103 |
17692319 | Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys. | 2008 Feb |
1 |
| 104 |
17991883 | Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. | 2008 Feb 1 |
1 |
| 105 |
18021271 | A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy. | 2008 Mar |
1 |
| 106 |
18172037 | Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. | 2008 Jan 22 |
3 |
| 107 |
18199798 | ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy. | 2008 Apr |
2 |
| 108 |
18281370 | Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension. | 2008 Jun 1 |
1 |
| 109 |
18310294 | Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptor. | 2008 Mar |
1 |
| 110 |
18360050 | Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study. | 2008 Feb |
2 |
| 111 |
18403595 | Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. | 2008 May |
2 |
| 112 |
18414380 | Inhibition of the rapid component of the delayed rectifier potassium current in ventricular myocytes by angiotensin II via the AT1 receptor. | 2008 May |
1 |
| 113 |
18497466 | Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study. | 2008 Mar |
1 |
| 114 |
18573259 | Differential mechanisms of angiotensin II and PDGF-BB on migration and proliferation of coronary artery smooth muscle cells. | 2008 Aug |
1 |
| 115 |
18674515 | The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan. | 2008 Sep 15 |
1 |
| 116 |
19227608 | [The pleiotropic effects of losartan--the importance of decreasing uric acid level]. | 2008 Oct |
1 |
| 117 |
16925472 | Role of brain angiotensin AT1 receptor in the carbachol-induced natriuresis and expression of nNOS in the locus coeruleus and proximal convoluted tubule. | 2007 |
2 |
| 118 |
17158338 | Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. | 2007 Jan 5 |
1 |
| 119 |
17186003 | Selective AT1 receptor antagonism enhances sympathetically mediated vasoconstriction in man. | 2007 Jan |
1 |
| 120 |
17241875 | Actions by angiotensin II on esophageal contractility in humans. | 2007 Jan |
1 |
| 121 |
17409316 | Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. | 2007 May |
1 |
| 122 |
17409317 | Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. | 2007 May |
1 |
| 123 |
17481528 | Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. | 2007 May |
1 |
| 124 |
17630322 | The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. | 2007 Dec |
2 |
| 125 |
17636081 | Larger anti-adipogenic effect of angiotensin II on omental preadipose cells of obese humans. | 2007 Jul |
1 |
| 126 |
17651610 | [Losartan inhibited angiotensin induced human lung fibroblast transformation and collagen synthesis]. | 2007 Apr |
5 |
| 127 |
17666345 | [Peroxisome proliferator-activated receptor activator troglitazone inhibits angiotensin II-stimulated secretion of vasoactive factors by endothelial cells]. | 2007 Jul |
4 |
| 128 |
17683495 | Hepatic conversion of angiotensin I and the portal hypertensive response to angiotensin II in normal and regenerating liver. | 2007 Sep |
1 |
| 129 |
17823205 | Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium. | 2007 Nov 1 |
2 |
| 130 |
17888412 | Angiotensin II increases evoked release at the frog neuromuscular junction through a receptor sensitive to A779. | 2007 Oct 17 |
1 |
| 131 |
17900533 | Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro. | 2007 Nov 23 |
1 |
| 132 |
18037773 | Design and baseline characteristics of an observational study in Japanese patients with hypertension: Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH). | 2007 Sep |
2 |
| 133 |
18416173 | [State of vasoregulative function of vascular endothelium and cardiohemodynamics in patients with chronic obstructive diseases of the lung (CODL) treated with losartan]. | 2007 Jul-Sep |
2 |
| 134 |
15953627 | Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes. | 2006 |
1 |
| 135 |
16478976 | AT1 receptor-mediated accumulation of extracellular angiotensin II in proximal tubule cells: role of cytoskeleton microtubules and tyrosine phosphatases. | 2006 Aug |
4 |
| 136 |
16505203 | The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species. | 2006 Apr |
2 |
| 137 |
16553578 | Losartan: lessons learned from the RENAAL study. | 2006 Apr |
1 |
| 138 |
16565246 | Economic evaluation of angiotensin receptor blockers in type 2 diabetes, hypertension, and nephropathy. | 2006 Apr |
1 |
| 139 |
16572114 | Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. | 2006 May |
2 |
| 140 |
16641152 | Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy. | 2006 Jun |
1 |
| 141 |
16761903 | The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathy. | 2006 |
2 |
| 142 |
16768124 | [Clinical utility of angiotensin II receptor antagonist]. | 2006 Jun |
1 |
| 143 |
16787961 | Angiotensin II decreases system A amino acid transporter activity in human placental villous fragments through AT1 receptor activation. | 2006 Nov |
1 |
| 144 |
16829707 | Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes. | 2006 Aug |
1 |
| 145 |
16860167 | Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension. | 2006 Jun |
1 |
| 146 |
16949466 | Role of anemia in progression of chronic kidney disease. | 2006 Jul |
1 |
| 147 |
16982630 | Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. | 2006 Nov 17 |
1 |
| 148 |
17009077 | Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study. | 2006 Sep |
2 |
| 149 |
17175314 | Prevention of interstitial fibrosis of renal allograft by angiotensin II blockade. | 2006 Dec |
1 |
| 150 |
17699284 | Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. | 2006 Jul |
1 |